{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T04:16:07Z","timestamp":1769055367706,"version":"3.49.0"},"reference-count":39,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.3892\/mmr.2015.4329","type":"journal-article","created":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T07:08:59Z","timestamp":1442300939000},"page":"6895-6902","source":"Crossref","is-referenced-by-count":18,"title":["Therapeutic effects of the dipeptidyl peptidase-IV inhibitor, sitagliptin, on non-alcoholic steatohepatitis in FLS-ob\/ob male mice"],"prefix":"10.3892","volume":"12","author":[{"given":"TAKUMI","family":"ONOYAMA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MASAHIKO","family":"KODA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TOSHIAKI","family":"OKAMOTO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MANABU","family":"KISHINA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TOMOMITSU","family":"MATONO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TAKAAKI","family":"SUGIHARA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YOSHIKAZU","family":"MURAWAKI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015,9,15]]},"reference":[{"key":"key20180108021733_b1-mmr-12-05-6895","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.21006","article-title":"Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob\/ob mice","volume":"43","author":"Ding","year":"2006","journal-title":"Hepatology"},{"key":"key20180108021733_b2-mmr-12-05-6895","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/44.5.8627002","article-title":"Organ distribution of aminopeptidase A and dipeptidyl peptidase IV in normal mice","volume":"44","author":"Mentzel","year":"1996","journal-title":"J Histochem Cytochem"},{"key":"key20180108021733_b3-mmr-12-05-6895","first-page":"431","article-title":"Tissue distribution of the T cell activation antigen Ta1. Serological, immunohistochemical and biochemical investigations","volume":"74","author":"Heike","year":"1988","journal-title":"Clin Exp Immunol"},{"key":"key20180108021733_b4-mmr-12-05-6895","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1365-3083.2001.00984.x","article-title":"CD26: A multi-functional integral membrane and secreted protein of activated lymphocytes","volume":"54","author":"Gorrell","year":"2001","journal-title":"Scand J Immunol"},{"key":"key20180108021733_b5-mmr-12-05-6895","doi-asserted-by":"crossref","first-page":"19215","DOI":"10.1016\/S0021-9258(19)47289-X","article-title":"Distribution of adenosine deaminase-complexing protein in murine tissues","volume":"264","author":"Dinjens","year":"1989","journal-title":"J Biol Chem"},{"key":"key20180108021733_b6-mmr-12-05-6895","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/10606820213687","article-title":"Structure-function of the glucagon receptor family of G protein-coupled receptors: The glucagon, GIP, GLP-1 and GLP-2 receptors","volume":"8","author":"Brubaker","year":"2002","journal-title":"Receptors Channels"},{"key":"key20180108021733_b7-mmr-12-05-6895","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1515\/JPEM.2010.23.1-2.101","article-title":"Changes of dipeptidyl peptidase IV (DPP-IV) in obese children with weight loss: Relationships to peptide YY, pancreatic peptide and insulin sensitivity","volume":"23","author":"Reinehr","year":"2010","journal-title":"J Pediatr Endocrinol Metab"},{"key":"key20180108021733_b8-mmr-12-05-6895","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1365-2567.1997.00230.x","article-title":"Induction of the 2B9 antigen\/dipeptidyl peptidase IV\/CD26 on human natural killer cells by IL-2, IL-12 or IL-15","volume":"91","author":"Yamabe","year":"1997","journal-title":"Immunology"},{"key":"key20180108021733_b9-mmr-12-05-6895","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.2741\/2844","article-title":"Role of CD26\/dipeptidyl peptidase IV in human T cell activation and function","volume":"13","author":"Ohnuma","year":"2008","journal-title":"Front Biosci"},{"key":"key20180108021733_b10-mmr-12-05-6895","doi-asserted-by":"crossref","first-page":"6825","DOI":"10.1073\/pnas.0631828100","article-title":"Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance","volume":"100","author":"Conarello","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108021733_b11-mmr-12-05-6895","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.3748\/wjg.v19.i15.2298","article-title":"Dipeptidyl peptidase-4: A key player in chronic liver disease","volume":"19","author":"Itou","year":"2013","journal-title":"World J Gastroenterol"},{"key":"key20180108021733_b12-mmr-12-05-6895","first-page":"729","article-title":"Increased hepatic expression of dipeptidyl peptidase-4 in non-alcoholic fatty liver disease and its association with insulin resistance and glucose metabolism","volume":"5","author":"Miyazaki","year":"2012","journal-title":"Mol Med Rep"},{"key":"key20180108021733_b13-mmr-12-05-6895","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S1665-2681(19)31905-2","article-title":"Dipeptidyl peptidase IV (DDP IV) in NASH patients","volume":"6","author":"Balaban","year":"2007","journal-title":"Ann Hepatol"},{"key":"key20180108021733_b14-mmr-12-05-6895","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jhep.2010.09.032","article-title":"Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase","volume":"54","author":"Ben-Shlomo","year":"2011","journal-title":"J Hepatol"},{"key":"key20180108021733_b15-mmr-12-05-6895","first-page":"269","article-title":"The FLS mouse: A new inbred strain with spontaneous fatty liver","volume":"49","author":"Soga","year":"1999","journal-title":"Lab Anim Sci"},{"key":"key20180108021733_b16-mmr-12-05-6895","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1538\/expanim.59.407","article-title":"Insulin resistance, steatohepatitis and hepatocellular carcinoma in a new congenic strain of Fatty Liver Shionogi (FLS) mice with the Lep (ob) gene","volume":"59","author":"Soga","year":"2010","journal-title":"Exp Anim"},{"key":"key20180108021733_b17-mmr-12-05-6895","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1872-034X.2012.01101.x","article-title":"Fatty liver Shionogi ob\/ob mouse: A new candidate for a non-alcoholic steatohepatitis model","volume":"43","author":"Sugihara","year":"2013","journal-title":"Hepatol Res"},{"key":"key20180108021733_b18-mmr-12-05-6895","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.diabres.2014.04.028","article-title":"Sitagliptin attenuates methionine\/choline-deficient diet-induced steatohepatitis","volume":"105","author":"Jung","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"key20180108021733_b19-mmr-12-05-6895","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1074\/jbc.271.1.486","article-title":"Molecular cloning of F4\/80, a murine macrophage-restricted cell surface glycoprotein with homology to the G-protein-linked transmembrane 7 hormone receptor family","volume":"271","author":"McKnight","year":"1996","journal-title":"J Biol Chem"},{"key":"key20180108021733_b20-mmr-12-05-6895","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data usingreal-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20180108021733_b21-mmr-12-05-6895","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"key20180108021733_b22-mmr-12-05-6895","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.numecd.2008.12.015","article-title":"Hepatic lipid metabolism and non-alcoholic fatty liver disease","volume":"19","author":"Tessari","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"key20180108021733_b23-mmr-12-05-6895","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease","volume":"346","author":"Angulo","year":"2002","journal-title":"N Engl J Med"},{"key":"key20180108021733_b24-mmr-12-05-6895","first-page":"17","article-title":"Diabetes mellitus, obesity and hepatic steatosis","volume":"13","author":"Youssef","year":"2002","journal-title":"Semin Gastrointest Dis"},{"key":"key20180108021733_b25-mmr-12-05-6895","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1381\/096089206776944959","article-title":"Peptide YY(1\u201336) and peptide YY(3\u201336): Part I. Distribution, release and actions","volume":"16","author":"Ballantyne","year":"2006","journal-title":"Obes Surg"},{"key":"key20180108021733_b26-mmr-12-05-6895","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1007\/s00125-006-0340-2","article-title":"Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes","volume":"49","author":"Matikainen","year":"2006","journal-title":"Diabetologia"},{"key":"key20180108021733_b27-mmr-12-05-6895","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/j.1463-1326.2007.00839.x","article-title":"Efficacy and safety of sitagliptin when added to ongoing metformin therapy in patients with type 2 diabetes","volume":"10","author":"Scott","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"key20180108021733_b28-mmr-12-05-6895","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.3748\/wjg.14.2474","article-title":"Nonalcoholic fatty liver disease: An overview of current insights in pathogenesis, diagnosis and treatment","volume":"14","author":"Schreuder","year":"2008","journal-title":"World J Gastroenterol"},{"key":"key20180108021733_b29-mmr-12-05-6895","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.2337\/db10-1338","article-title":"Diet-induced adipose tissue inflammation and liver steatosis are prevented by DPP-4 inhibition in diabetic mice","volume":"60","author":"Shirakawa","year":"2011","journal-title":"Diabetes"},{"key":"key20180108021733_b30-mmr-12-05-6895","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2147\/VHRM.S10952","article-title":"Weight neutrality with the DPP-4 inhibitor, vildagliptin: Mechanistic basis and clinical experience","volume":"6","author":"Foley","year":"2010","journal-title":"Vasc Health Risk Manag"},{"key":"key20180108021733_b31-mmr-12-05-6895","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1042\/bj20020430","article-title":"New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: A role for the transcription factor sterol regulatory element binding protein-1c","volume":"366","author":"Foufelle","year":"2002","journal-title":"Biochem J"},{"key":"key20180108021733_b32-mmr-12-05-6895","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/hep.20920","article-title":"Insulin resistance: A metabolic pathway to chronic liver disease","volume":"42","author":"Bugianesi","year":"2005","journal-title":"Hepatology"},{"key":"key20180108021733_b33-mmr-12-05-6895","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1021\/jm0493156","article-title":"(2R)-4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro(1,2,4) triazolo(4,3-a) pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl) butan-2-amine: A potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes","volume":"48","author":"Kim","year":"2005","journal-title":"J Med Chem"},{"key":"key20180108021733_b34-mmr-12-05-6895","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0005-2760(96)00168-3","article-title":"Microsomal triglyceride transfer protein","volume":"1345","author":"Wetterau","year":"1997","journal-title":"Biochim Biophys Acta"},{"key":"key20180108021733_b35-mmr-12-05-6895","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jhep.2006.09.007","article-title":"Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient mice","volume":"46","author":"Zamara","year":"2007","journal-title":"J Hepatol"},{"key":"key20180108021733_b36-mmr-12-05-6895","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/hep.22952","article-title":"CCR2 promotes hepatic fibrosis in mice","volume":"50","author":"Seki","year":"2009","journal-title":"Hepatology"},{"key":"key20180108021733_b37-mmr-12-05-6895","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1042\/CS20110515","article-title":"Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis","volume":"123","author":"Galastri","year":"2012","journal-title":"Clin Sci (Lond)"},{"key":"key20180108021733_b38-mmr-12-05-6895","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.2337\/dc10-0187","article-title":"The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: Possible role of stromal-derived factor-1alpha","volume":"33","author":"Fadini","year":"2010","journal-title":"Diabetes Care"},{"key":"key20180108021733_b39-mmr-12-05-6895","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00535-013-0783-4","article-title":"Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats","volume":"49","author":"Kaji","year":"2013","journal-title":"J Gastroenterol"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2015.4329\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T21:12:16Z","timestamp":1653167536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2015.4329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,15]]},"references-count":39,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,9,15]]},"published-print":{"date-parts":[[2015,11]]}},"alternative-id":["10.3892\/mmr.2015.4329"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2015.4329","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,15]]}}}